Evolution Announce Human Capital Partnership with Genomics Startup QuantiHealth

Evolution Global Talent Attraction recently signed a contract to provide human capital to newly formed company QuantiHealth in China. QuantiHealth was founded by Zhao Bowen, who was named as one

Arysta LifeScience announce exclusive commercial partnership at Plant Impact Investors Day

Evolution Global Talent Attraction were recently invited to crop enhancement company Plant Impact’s Investors Day at Rothamsted, where Plant Impact announced the commercial launch of BANZAI, a novel product that

Research Chemicals Leader Alfa Aesar to be acquired by Thermo Fisher Scientific

Thermo Fisher Scientific have signed a definitive agreement to acquire Alfa Aesar, a leading global manufacturer of research chemicals, for £256 million (approximately $405 million USD) in cash. Alfa Aesar’s

Genentech and Regeneron win Thomson Reuters Allicense Awards for Top BioPharma Deals of the Year

The Intellectual Property and Science business of Thomson Reuters recently honoured Genentech Partnering and Seragon, and Regeneron and Avalanche with the Allicense 2015 Breakthrough Award for Deals of the Year.

Merck Millipore Acquire Exclusive Rights to Singulex Single Molecule Counting Technology

Merck Millipore and Singulex, the developer and leading provider of Single Molecule Counting (SMC™) technology for clinical diagnostics and scientific discovery, have announced that they have entered into a definitive

Advanced Cell Diagnostics raises $22 million USD in latest round of financing

Advanced Cell Diagnostics (ACD) have raised a further $22 million in Series C equity financing, with proceeds to be used to accelerate their entry into the research and clinical diagnostics

Merck Acquisition of Sigma-Aldrich receives conditional clearance from European Commission

Sigma-Aldrich’s acquisition by Merck has been conditionally cleared by the European Commission, and has received full clearance from the Chinese Ministry of Commerce. Merck and Sigma have already cleared from

Evolution Global Talent Attraction featured on GEN JobWatch

Evolution founder and Managing Director Dr. Jason Beckwith was recently featured on monthly Genetic Engineering & Biotechnology News column JobWatch. Dr. Beckwith offered GEN an insight into the hiring practices

Sigma-Aldrich Announce Q1 2015 Sales Figures

Sigma-Aldrich Corporation have posted strong Q1 2015 results ahead of their planned merger with Merck later this year. Sigma reported quarterly sales of $676 million, with an organic growth rate

Merck appoints Udit Batra to head combined life science business ahead of Sigma-Aldrich acquisition

Udit Batra has been appointed to lead the combined life science business of Merck Millipore and Sigma-Aldrich once the acquisition of Sigma-Aldrich has been successfully completed later this year. Udit

Scottish CRO BioOutsource Acquired by Sartorius Stedim Biotech

Scottish Contract Research Organisation BioOutsource have been acquired by global biopharmaceutical supplier Sartorius Stedim Biotech (SSB) for an undisclosed amount. The takeover strengthens SSB’s service portfolio throughout the drug development

Sigma-Aldrich Launch New APAC Headquarters and Cell Culture Technical Center

Global Life Science and High Technology company Sigma-Aldrich announced the opening of their new Asia Pacific headquarters and state-of-the-art Cell Culture Technical Center at the Biopolis Research Park in Singapore.

Bio-Rad Reports Strong Fourth-Quarter and Full-Year 2014 Financial Results

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, announced financial results today for the fourth quarter and fiscal year ended

Sigma-Aldrich Reports Record Full-Year 2014 Sales

Sigma-Aldrich (NASDAQ – SIAL) Reports Record Full-Year 2014 Sales Of $2.79 Billion And Record Adjusted Diluted EPS Of $4.37. Reports Q4 2014 Adjusted Diluted EPS Of $1.14 And Organic Sales

Merck, Sanofi, Syngenta & GSK announce full year results for 2014

Pharma giants Merck, Sanofi & GSK announced their full-year results for 2014 this week, as did global AgroChemical multinational Syngenta. Syngenta reported sales of $15.1 billion USD, achieving their integrates